Matisse Pharmaceuticals
PrivateLast Round
Grant
Jun 26, 2025
Total Funding Raised
$610,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Matisse Pharmaceuticals is a biopharmaceutical company developing a treatment for sepsis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Matisse Pharmaceuticals Comparables
Compare Matisse Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inotrem | 86% | |
| Adrenomed AG | 83% | |
| RevImmune | 81% | |
Matisse Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 26, 2025 | ||||
| VC Round | Jan 4, 2024 | ||||
| VC Round | Mar 1, 2020 | ||||
| Seed | Nov 15, 2016 |
Matisse Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mibiton Foundation | Seed |
| Eurostars SME programme | Grant |
| Brightlands Venture Partners | VC Round, Seed |
| LIOF | VC Round, Seed |
| Particon B.V. | Seed |
| Netherlands Enterprise Agency | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 176% MoM.
- Feb 21, 2026
Grew 67% QoQ, from 6 to 10 employees.
Matisse Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Matisse Pharmaceuticals's valuation, stock price, and market status.